According to our (Global Info Research) latest study, the global CMAB009 market size was valued at US$ 95.69 million in 2025 and is forecast to a readjusted size of US$ 252 million by 2032 with a CAGR of 7.3% during review period.
CMAB009 is a recombinant chimeric anti‑epidermal growth factor receptor monoclonal antibody and classified as a biosimilar of Cetuximab. It specifically binds to the EGFR target on the surface of tumor cells, blocks receptor‑mediated signaling pathways, inhibits the proliferation, invasion and metastasis of tumor cells, and induces tumor cell apoptosis. With stable efficacy and favorable safety profiles, CMAB009 is clinically applied for the treatment of a variety of solid malignant tumors. It effectively meets the medical demands in the field of targeted therapy and provides high‑quality and more accessible biopharmaceutical treatment options for tumor patients.In 2025, global CMAB009 production reached approximately 3.26 Million Vials.
CMAB009 is an important targeted anti-tumor biological agent in the domestic medical market, serving as a high-quality biosimilar of cetuximab. With the continuous expansion of clinical application scenarios for solid tumor treatment and the rising demand for affordable targeted drugs, this product enjoys broad market development prospects. Benefiting from policy support for innovative biological medicines and the accelerated process of import substitution, the drug is gradually increasing its penetration in hospital terminals and oncology treatment fields. Meanwhile, it faces competition from other EGFR targeted preparations and similar biosimilar products in the industry. Through continuous clinical promotion and optimized commercial layout, CMAB009 will further enhance its market competitiveness and expand its application scope in global anti-tumor treatment.
This report is a detailed and comprehensive analysis for global CMAB009 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CMAB009 market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CMAB009 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CMAB009 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CMAB009 market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CMAB009
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CMAB009 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mabpharm, Jiangsu Simcere Zaiming Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
CMAB009 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 mg (10 mL)/vial
50 mg (5 mL)/vial
Market segment by Combination Therapy
Combined use of CMAB009 and Paclitaxel
CMAB009 Combined with Bevacizumab
Market segment by Route Of Administration
Intravenous Drip Infusion
Intravenous Infusion
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Colorectal Cancer
Head And Neck Squamous Cell Carcinoma
Metastatic Solid Tumor
Others
Major players covered
Mabpharm
Jiangsu Simcere Zaiming Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CMAB009 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CMAB009, with price, sales quantity, revenue, and global market share of CMAB009 from 2021 to 2026.
Chapter 3, the CMAB009 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CMAB009 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and CMAB009 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CMAB009.
Chapter 14 and 15, to describe CMAB009 sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on CMAB009. Industry analysis & Market Report on CMAB009 is a syndicated market report, published as Global CMAB009 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of CMAB009 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.